RT Journal Article SR Electronic T1 Frailty after lung transplantation is associated with impaired health-related quality of life and mortality JF Thorax JO Thorax FD BMJ Publishing Group Ltd and British Thoracic Society SP 669 OP 678 DO 10.1136/thoraxjnl-2019-213988 VO 75 IS 8 A1 Venado, Aida A1 Kolaitis, Nicholas A A1 Huang, Chiung-Yu A1 Gao, Ying A1 Glidden, David V A1 Soong, Allison A1 Sutter, Nicole A1 Katz, Patricia P A1 Greenland, John R A1 Calabrese, Daniel R A1 Hays, Steven R A1 Golden, Jeffrey A A1 Shah, Rupal J A1 Leard, Lorriana E A1 Kukreja, Jasleen A1 Deuse, Tobias A1 Wolters, Paul J A1 Covinsky, Kenneth A1 Blanc, Paul D A1 Singer, Jonathan P YR 2020 UL http://thorax.bmj.com/content/75/8/669.abstract AB Background Lung transplantation and related medications are associated with pathobiological changes that can induce frailty, a state of decreased physiological reserve. Causes of persistent or emergent frailty after lung transplantation, and whether such transplant-related frailty is associated with key outcomes, are unknown.Methods Frailty and health-related quality of life (HRQL) were prospectively measured repeatedly for up to 3 years after lung transplantation. Frailty, quantified by the Short Physical Performance Battery (SPPB), was tested as a time-dependent binary and continuous predictor. The association of transplant-related frailty with HRQL and mortality was evaluated using mixed effects and Cox regression models, respectively, adjusting for age, sex, ethnicity, diagnosis, and for body mass index and lung function as time-dependent covariates. We tested the association between measures of body composition, malnutrition, renal dysfunction and immunosuppressants on the development of frailty using mixed effects models with time-dependent predictors and lagged frailty outcomes.Results Among 259 adults (56% male; mean age 55.9±12.3 years), transplant-related frailty was associated with lower HRQL. Frailty was also associated with a 2.5-fold higher mortality risk (HR 2.51; 95% CI 1.21 to 5.23). Further, each 1-point worsening in SPPB was associated, on average, with a 13% higher mortality risk (HR 1.13; 95% CI 1.04 to 1.23). Secondarily, we found that sarcopenia, underweight and obesity, malnutrition, and renal dysfunction were associated with the development of frailty after transplant.Conclusions Transplant-related frailty is associated with lower HRQL and higher mortality in lung recipients. Abnormal body composition, malnutrition and renal dysfunction may contribute to the development of frailty after transplant. Confirming the role of these potential contributors and developing interventions to mitigate frailty may improve lung transplant success.